• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Effect of Pharmacy-Driven Education on the Amount of Appropriately Administered Tetanus Vaccines in the Emergency Department.药学驱动教育对急诊科破伤风疫苗合理接种量的影响
Hosp Pharm. 2019 Feb;54(1):45-50. doi: 10.1177/0018578718769239. Epub 2018 Apr 18.
2
Pertussis vaccination in adult trauma patients: Are we missing an opportunity?成年创伤患者的百日咳疫苗接种:我们是否错失了一个机会?
Surgery. 2015 Sep;158(3):602-7. doi: 10.1016/j.surg.2015.03.060. Epub 2015 May 29.
3
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.预防成人破伤风、白喉和百日咳:免疫实践咨询委员会(ACIP)关于使用破伤风类毒素、吸附白喉类毒素和无细胞百日咳疫苗的建议,以及在医疗感染控制实践咨询委员会(HICPAC)支持下,ACIP关于医护人员使用破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗(Tdap)的建议。
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.
4
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
5
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).孕妇和产后妇女及其婴儿百日咳、破伤风和白喉的预防——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51.
6
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防:破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
7
Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.现场记录:在急诊部门使用破伤风、白喉和百日咳疫苗(Tdap)- 亚利桑那州,2009-2010 年。
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):55-6.
8
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳(Tdap)疫苗与破伤风和白喉(Td)疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。
Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.
9
Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.药师主导的对妇女医院新生儿密切接触者的 Tdap 疫苗接种。
Vaccine. 2014 Jan 16;32(4):521-5. doi: 10.1016/j.vaccine.2013.11.035. Epub 2013 Nov 20.
10
Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.孕期接种破伤风、白喉和无细胞百日咳疫苗与降低婴儿急性呼吸道感染风险
Vaccine. 2017 Oct 9;35(42):5603-5610. doi: 10.1016/j.vaccine.2017.08.041. Epub 2017 Sep 12.

引用本文的文献

1
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis.药师参与对免疫接种率和其他结果的影响:更新的系统评价和荟萃分析。
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1499-1513.e16. doi: 10.1016/j.japh.2022.06.008. Epub 2022 Jun 24.
2
Using an Online Vaccination Registry to Confirm Tetanus Status in Children with Tetanus-prone Wounds.利用在线疫苗接种登记处确认破伤风易患伤口患儿的破伤风状况。
West J Emerg Med. 2020 Aug 21;21(5):1140-1146. doi: 10.5811/westjem.2020.6.46582.

本文引用的文献

1
Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗接种对百日咳免疫逐渐减弱时代 11 至 18 岁人群报告百日咳病例的影响:一项随访分析。
JAMA Pediatr. 2016 May 1;170(5):453-8. doi: 10.1001/jamapediatrics.2015.4875.
2
Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.破伤风、白喉和无细胞百日咳(Tdap)疫苗在伤口管理中的使用对医疗保健费用和百日咳病例的影响。
J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c. doi: 10.18553/jmcp.2015.21.1.88.
3
Waning protection after fifth dose of acellular pertussis vaccine in children.儿童接种五剂无细胞百日咳疫苗后的保护作用减弱。
N Engl J Med. 2012 Sep 13;367(11):1012-9. doi: 10.1056/NEJMoa1200850.
4
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.更新的破伤风类毒素、白喉类毒素和无细胞百日咳(Tdap)疫苗在 65 岁及以上成人中的使用建议 - 免疫实践咨询委员会(ACIP),2012 年。
MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70.
5
Should we test for tetanus immunity in all emergency department patients with wounds?所有因创伤而就诊于急诊部的患者都应该检测破伤风免疫力吗?
Emerg Med J. 2013 Mar;30(3):177-9. doi: 10.1136/emermed-2012-201193. Epub 2012 Jun 8.
6
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose.在先前接种一剂 Tdap(吸附破伤风类毒素、白喉类毒素和无细胞百日咳疫苗)后 4-5 年,对青少年和成年人进行破伤风类毒素、减量白喉类毒素和无细胞百日咳疫苗吸附(Tdap)加强免疫的耐受性和抗体应答。
Vaccine. 2011 Oct 26;29(46):8459-65. doi: 10.1016/j.vaccine.2011.07.068. Epub 2011 Jul 29.
7
Tetanus surveillance --- United States, 2001-2008.破伤风监测-美国,2001-2008 年。
MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):365-9.
8
The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.在先前破伤风疫苗接种后不到 2 年内接种破伤风-白喉-无细胞百日咳疫苗(Tdap)的安全性:在呼吸道疾病爆发期间进行的一次医疗保健人员大规模疫苗接种活动期间的经验。
Vaccine. 2010 Nov 23;28(50):8001-7. doi: 10.1016/j.vaccine.2010.09.034. Epub 2010 Sep 25.
9
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.在健康年轻成年人中,Td-IPV加强免疫后1个月接种Tdap-IPV的安全性:一项安慰剂对照试验。
Hum Vaccin. 2009 May;5(5):315-21. doi: 10.4161/hv.5.5.6911. Epub 2009 May 1.
10
Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study.改善急诊科破伤风预防措施:一项前瞻性、双盲成本效益研究。
Emerg Med J. 2007 Sep;24(9):648-53. doi: 10.1136/emj.2007.048520.

药学驱动教育对急诊科破伤风疫苗合理接种量的影响

The Effect of Pharmacy-Driven Education on the Amount of Appropriately Administered Tetanus Vaccines in the Emergency Department.

作者信息

Fletcher Meghan, Rankin Shannon, Sarangarm Preeyaporn

机构信息

The University of New Mexico, Health Sciences Center, Albuquerque, USA.

出版信息

Hosp Pharm. 2019 Feb;54(1):45-50. doi: 10.1177/0018578718769239. Epub 2018 Apr 18.

DOI:10.1177/0018578718769239
PMID:30718934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333948/
Abstract

Tetanus vaccinations for wound prophylaxis are routinely administered in emergency departments (ED). Current recommendations from the Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) regarding tetanus administration for wound prophylaxis differentiate between the tetanus and diphtheria (Td) and the tetanus, diphtheria, acellular pertussis (Tdap) formulations and when they should be administered. Lack of knowledge regarding these recommendations, different formulations, and techniques to locate patient immunization history can lend to increased duplicate and inappropriate vaccinations. The purpose of this prospective, interventional study with a historical control was to evaluate the impact of a pharmacy-driven education series on the proportion of duplicate and inappropriate tetanus vaccinations administered in a level I trauma center ED. Three months of tetanus vaccinations administered in the ED after this education were analyzed and compared with a historical control. The primary outcome is the percentage of vaccinations considered duplicates (previous vaccination within the past 5 years) when patients' medical record was reviewed for immunization history. Secondary end points include the percentage of vaccinations considered nonadherent (according to current CDC-ACIP guidelines), the total cost of all duplicate vaccinations, and the percentage of vaccination orders that had the wrong formulation administered. The percentage of duplicate vaccinations decreased from 9.9% (25 vaccinations) to 5.5% (14 vaccinations) (P = .067) from the preintervention group to the postintervention group. Nonadherent vaccinations compiled 3.6% versus 2.8% of the vaccinations (P = .611) and incorrect formulations given were 18.2% versus 11.4% (P = .176) in the preintervention and postintervention groups, respectively. The study suggests that multiple formulations of tetanus vaccinations and fragmented documentation of immunizations increase the prevalence of medication errors related to tetanus vaccinations. It also indicates that interventions more enduring than education are required to prevent these errors.

摘要

急诊科(ED)通常会进行破伤风疫苗接种以预防伤口感染。疾病控制与预防中心(CDC)以及免疫实践咨询委员会(ACIP)目前关于破伤风疫苗接种以预防伤口感染的建议,区分了破伤风和白喉(Td)疫苗以及破伤风、白喉、无细胞百日咳(Tdap)疫苗制剂,以及它们的接种时机。由于对这些建议、不同制剂以及查找患者免疫史的技术缺乏了解,可能会导致重复接种和不适当接种的情况增加。这项具有历史对照的前瞻性干预研究的目的是评估由药房主导的教育系列对一级创伤中心急诊科重复和不适当破伤风疫苗接种比例的影响。对此次教育后急诊科三个月内的破伤风疫苗接种情况进行了分析,并与历史对照进行比较。主要结果是在查看患者病历以了解免疫史时,被视为重复接种(过去5年内曾接种过)的疫苗接种百分比。次要终点包括被视为不符合接种要求(根据当前CDC - ACIP指南)的疫苗接种百分比、所有重复接种的总费用,以及接种了错误制剂的疫苗接种订单百分比。从干预前组到干预后组,重复接种的百分比从9.9%(25次接种)降至5.5%(14次接种)(P = 0.067)。不符合接种要求的疫苗接种在干预前组和干预后组分别占疫苗接种的3.6%和2.8%(P = 0.611),接种错误制剂的比例分别为18.2%和11.4%(P = 0.176)。该研究表明,破伤风疫苗的多种制剂以及免疫记录的不完整增加了与破伤风疫苗接种相关的用药错误发生率。研究还表明,需要比教育更持久的干预措施来预防这些错误。